Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

500 patients to reveal which chemo port dressings cause skin problems

NCT ID NCT07158879

Knowledge-focused Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will follow 500 adults starting chemotherapy with a chest port (a small device under the skin to deliver drugs). The goal is to measure how often skin reactions like itching or redness happen from the dressing that covers the port. Researchers will also look for factors that increase the risk of these reactions, such as the type of dressing or the chemotherapy drugs used.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help identify which dressings or treatments cause fewer skin reactions, leading to better comfort for chemotherapy patients.
What could go wrong
This is an observational study, not testing a new treatment. It may not find clear risk factors, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient with thoracic CCI treated with chemotherapy in a day hospital ward at the Institut Curie Paris or the Centre Hospitalier de Polynésie Française or the Uturoa Hospital (French Polynesia).

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over 18 years of age * New chemotherapy patients (1st line of treatment only) * Thoracic PAC Exclusion Criteria: * PICC Line and femoral PAC; * Patients undergoing treatment with bi-specific antibodies (e.g. tebentafusp); * Disunion requiring treatment * Patients treated for hematological cancer; * Persons deprived of their liberty or under guardianship (including curatorship); * Adults under court protection; * Inability to participate in the study for geographical, social or psychological reasons. * No inclusion of persons covered by articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code (e.g. minors, protected adults, etc.). * Opposition to data use

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

skin disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Skin diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier de Polynésie Française CHPF

    NOT_YET_RECRUITING

    Pirae, 98716, French Polynesia

  • Hôpital Uturoa

    NOT_YET_RECRUITING

    Uturoa, 98735, French Polynesia

  • Institut Curie

    RECRUITING

    Paris, 75248, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.